Results 261 to 270 of about 692,682 (292)

Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region. [PDF]

Diabetes Ther
Khan NE, Al Shaikh AAM, Hassoun AAK, Hassan AM, Salah MM, Al Abdella NA, Safarini SSM, Al Dahi WA, Akil YA.   +8 more
europepmc   +1 more source

Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring. [PDF]

J Diabetes Investig
Kawaguchi Y, Hajika Y, Rinka M, Masumoto K, Sawa J, Hamazaki K, Kumeda Y.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial

Diabetes, obesity and metabolism, 2022
To determine the effectiveness and safety of early combination of insulin glargine with intravenous (IV) insulin infusion compared with IV insulin infusion alone in the management of diabetic ketoacidosis (DKA).
Kitti Thammakosol, Chutintorn Sriphrapradang   +1 more
semanticscholar   +1 more source

Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes

Diabetes/Metabolism Research Reviews, 2020
The aim of this study was to investigate the efficacy of exenatide and insulin glargine in patients with newly diagnosed type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD).
Lin Liu, Hongmei Yan, Mingfeng Xia, Lin Zhao, M. Lv, N. Zhao, Sheng-xiang Rao, X. Yao, Weiyun Wu, Bai-shen Pan, H. Bian, Xin Gao   +11 more
semanticscholar   +1 more source

Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second‐generation basal insulin analogues

Diabetes/Metabolism Research Reviews, 2020
For most people with type 2 diabetes (T2D), treatment intensification with the addition of basal insulin therapy is required to maintain glycaemic control.
A. Cheng, T. Bailey, D. Mauricio, R. Roussel   +3 more
semanticscholar   +1 more source

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

The Lancet, 2021
S. Prato, S. Kahn, I. Pávó, G. Weerakkody, Zhengyu Yang, J. Doupis, D. Aizenberg, A. Wynne, J. Riesmeyer, R. Heine, R. Wiese, A. Ahmann, S. Arora, E. Ball, Rafael Calderón, David Butuk, Leila Chaychi, Michael C. Chen, B. Curtis, R. Chochinov, C. Chow, Clancy L Cone, Lisa E. Connery, Gregorio Cortes-Maisonet, J. D. Souza, K. Dungan, David P. Bradley, J. Frias, Nashwa Gabra, L. Gaudiani, Luis Herandez-Vazquez, S. Hsia, Michael R Jardula, E. Klein, M. Kutner, Juan Loy, Francisco G Miranda, L. Nunez, Miguel Mujica-Baella, A. V. Murray, M. J. Oliver, Ramon Oritz-Carrasquillo, Betsy Palal, Michael T. Parke, A. Philis-Tsimikas, Raman S Purighalla, J. Rosenstock, A. Sathananthan, Courtney Shelton, K. Sivalingam, Ehab E. Sorial, J. Soufer, Helen L Stacey, L. Stonesifer, Stanley Stringam, J. T. Van, Jose B Vazquez-Tanus, Ramon Reyes, Michelle Welch, Najmuddin Karimjee, E. E. Martin, A. Arif, Timothy W Jennings, Neil J. Fraser, A. Bhargava, E. Davidson, L. Billings, Elizabeth A Barranco-Santana, Michael Dever, P. Walsh, Austina Cho, James W. Chu, J. Shubrook, A. Knouse, Venkatesh K. Nadar, Lorena Lewy-Alterbaum, M. Lillestol, Daniel J Humiston, Alexander White, R. Mayfield, F. Bitar, Fernando Cereto, C. Cuesta, L. D. T. Parreño, E. Gimeno, P. Mezquita-Raya, C. M. Portillo, Miguel Quesada Charneco, F. Madueño, S. T. Povedano, L. Vázquez, C. F. Montañana, Alfonso Soto González, Cristina Mistodie, Iosif Szilagyi, A. Filimon, N. Mîndrescu, L. Pop, M. Pascu, G. Negrişanu, D. Ciomos, V. Neacsu, Amalia Thury-Burileanu, Idit F. Liberty, Naftali Stern, Y. Sofer, J. Sack, Ilan Shimon, A. Tirosh, A. Ishay, Ofri Mosenzon Ninio, N. Shehadeh, J. Wainstein, Mahmud Darawsha, D. Skripova, Eva Pavleova, V. Donicova, Ludmila Kubincova, Dalibor Sosovec, Martina Merciakova, F. Boreky, E. St-Amour, Z. Yared, François Blouin, B. Ajala, N. Aggarwal, H. Bajaj, C. Tailor, A. Egan, Johnny O’Mahony, Natasha St.Onge, J. Conway, G. Augusto, J. Borges, M. A. Cerqueira, D. Franco, Tatiana Franco Hirakawa, Filipe D Souza, M. Hissa, L. M. Pechmann, C. P. Salim, L. A. Russo, Joselita M. Siqueira, Sonia A Sassone, Jorge A Glenny, M. Koretzky, A. Steinacher, S. E. Solis, Lucrecia Nardone, F. P. Manghi, Silvia Orio, Elizabeth Gelersztein, José Fretes, Pedro R F Calella, C. Zaidman, A. Chertkoff, S. Salzberg, C. Majul, Luis A Nevarez, R. Ortíz, Ramiro G Banda Elizondo, R. A. Villicaña, G. G. Gálvez, Cesar Calvo, A. Kościański, H. Rudzki, A. Stankiewicz, D. Sowiński, E. Krzyżagórska, Małgorzata Józefowska, Beata Matyjaszek-Matuszek, E. Franek, Ewa Skokowska, Anna Modzelewska, Ewa Szyprowska, R. Simpson, C. Gilfillan, D. Colquhoun, T. Davis, C. Morbey, Shannon E McCarthy, K. Kaur, L. Kemp, A. J. Shea, Y. Khalimov, Olga A. Miroshnichenko, I. Dvoryashina, I. Karpova, M. Kunitsyna, N. Vorokhobina, G. Galstyan, I. Bondar, E. Filippov, O. Ershova, H. Ou, Shih-Ting Tseng, Jung-Fu Chen, K. Tien, Chien-Ning Huang, Ching-Chu Chen, C. Hwu, T. Hsia, E. Pagkalos, Z. Mouslech, A. Bargiota, K. Kotsa   +205 more
semanticscholar   +1 more source

Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes

IEEE Transactions on Biomedical Engineering, 2020
Objective: Subcutaneous (sc) administration of long-acting insulin analogs is often employed in multiple daily injection (MDI) therapy of type 1 diabetes (T1D) to cover patient's basal insulin needs.
M. Schiavon, Roberto Visentin, Clemens Giegerich, T. Klabunde, C. Cobelli, C. Dalla Man   +5 more
semanticscholar   +1 more source

A novel peptide design aids in the expression and its simplified process of manufacturing of Insulin Glargine in Pichia pastoris

Applied Microbiology and Biotechnology, 2021
P. Hazra, S. Sreenivas, Krishnamurthy Venkatesan, M. B. Patale, A. Chatterjee, N. Ramprabu, Ajamoddin M Shaikh, Mutyalasetty Kusumanchi   +7 more
semanticscholar   +1 more source

Insulin glargine

Reactions weekly, 2022

semanticscholar   +1 more source